Recurrent Meningioma Clinical Trials in San Francisco, California
3 recruitingSan Francisco, California
Showing 1–3 of 3 trials
Recruiting
Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial MeningiomaRecurrent MeningiomaNF2 Gene Mutation
Alliance for Clinical Trials in Oncology124 enrolled780 locationsNCT02523014
Recruiting
Not Applicable
Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
MeningiomaRecurrent MeningiomaMeningioma, Malignant
University of California, San Francisco23 enrolled1 locationNCT06557512
Recruiting
Phase 2
Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma
Grade I Meningioma, AdultGrade II Meningioma, AdultGrade III Meningioma, Adult+1 more
Nancy Ann Oberheim Bush, MD37 enrolled1 locationNCT04659811